Quarterly report pursuant to Section 13 or 15(d)

Other current assets (Details)

v3.23.3
Other current assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Other current assets    
Research and development credits receivable $ 40,533 $ 30,162
Prepayments 11,973 9,472
Clinical materials 1,290 1,279
VAT receivable 1,372 490
Other current assets 1,683 1,927
Total $ 56,851 $ 43,330